Loading...
Loading...
Browse all stories on DeepNewz
VisitTrump Picks Johns Hopkins Surgeon Dr. Marty Makary to Lead FDA, Aims to Restore Trust and Address Chronic Diseases
Nov 23, 2024, 01:18 AM
President-elect Donald Trump has nominated Dr. Marty Makary, MD, MPH, FACS, a surgeon at Johns Hopkins University and a critic of COVID-19 mandates, to lead the U.S. Food and Drug Administration (FDA). Dr. Makary is known for his expertise in healthcare transparency, medical ethics, and for authoring over 300 scientific articles. The nomination requires Senate confirmation. Trump's choice signals a potential shift in FDA policies, as Dr. Makary has been a vocal opponent of pandemic lockdowns and has advocated for healthcare reforms. The president-elect stated that Dr. Makary will work to restore trust in the FDA and address the chronic disease epidemic.
View original story
Markets
No • 50%
Yes • 50%
Reputable public opinion polls or surveys
Yes • 50%
No • 50%
Official FDA announcements or policy documents
Healthcare Industry Pushback • 25%
Internal FDA Resistance • 25%
Senate Opposition • 25%
Public Criticism • 25%
Reports from credible news outlets and FDA press releases
Pandemic Response • 25%
Healthcare Transparency • 25%
Chronic Disease Management • 25%
Drug Approval Process • 25%
Official FDA policy documents or announcements